← Leaderboards
Sami Nimer Malek
University Of Michigan At Ann Arbor
$8,691,121
Attributed
$11,182,307
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,182,307 · 7
By mechanism
R01$10,850,859 · 6
R21$331,448 · 1
Top collaborators
- Yang Liu5 shared
- Hans-Guido Wendel5 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Jolanta Grembecka$12,187,788
- Tomasz Cierpicki$10,333,927
- Celina G Kleer$13,464,529
Others in their field
Top investigators on “Recurrence”
- Philip J Disaia · University Of California Irvine$95,481,777
- David Heimbrook · Leidos Biomedical Research, Inc.$87,033,539
- Wafaa M. El-Sadr · Columbia University Health Sciences$84,793,830
- Myron S Cohen · Family Health International$84,793,830
- Lawrence Corey · Fred Hutchinson Cancer Center$59,594,035
- Dan H. Barouch · Fred Hutchinson Cancer Center$59,594,035
Research focus
RecurrenceCellsMutationGene MutationGenesCohortBaseMolecularDisease RemissionRelapsePathway InteractionsFutureChemotherapyLeukemiaSamplingChronic Lymphocytic LeukemiaProgramsGenomicsBiologicalCessation Of LifeInsightMutantReportingPharmaceutical Preparations
Grant awards (27)
The Biology of Mutant STAT6 in Follicular Lymphoma$713,700
R01 · FY2025 · CA · contact PI
Genes regulating stem and progenitor cell expansion and relapse in Acute Myeloid Leukemia$458,698
R01 · FY2025 · CA · contact PI
The Biology of Mutant STAT6 in Follicular Lymphoma$339,008
R01 · FY2024 · CA · contact PI
The Biology of Mutant STAT6 in Follicular Lymphoma$349,713
R01 · FY2023 · CA · contact PI
Advancing biological and clinical applications of genomic Minimal Residual Disease detection in AML$410,483
R01 · FY2022 · CA · contact PI
The Biology of Mutant STAT6 in Follicular Lymphoma$356,850
R01 · FY2022 · CA · contact PI
Advancing biological and clinical applications of genomic Minimal Residual Disease detection in AML$418,860
R01 · FY2021 · CA · contact PI
Advancing biological and clinical applications of genomic Minimal Residual Disease detection in AML$429,758
R01 · FY2020 · CA · contact PI
The genomic pathogenesis of Follicular Lymphoma$504,983
R01 · FY2019 · CA · contact PI
Advancing biological and clinical applications of genomic Minimal Residual Disease detection in AML$416,864
R01 · FY2019 · CA · contact PI
The genomic pathogenesis of Follicular Lymphoma$520,601
R01 · FY2018 · CA · contact PI
Advancing biological and clinical applications of genomic Minimal Residual Disease detection in AML$429,758
R01 · FY2018 · CA · contact PI
The genomic pathogenesis of Follicular Lymphoma$541,994
R01 · FY2017 · CA · contact PI
Targeted Elimination of Cancer Stem Cells for AML Therapy$463,347
R01 · FY2017 · CA
The genomic pathogenesis of Follicular Lymphoma$541,994
R01 · FY2016 · CA · contact PI
Targeted Elimination of Cancer Stem Cells for AML Therapy$463,347
R01 · FY2016 · CA
The genomic pathogenesis of Follicular Lymphoma$556,205
R01 · FY2015 · CA · contact PI
Targeted Elimination of Cancer Stem Cells for AML Therapy$463,347
R01 · FY2015 · CA
Targeted Elimination of Cancer Stem Cells for AML Therapy$447,360
R01 · FY2014 · CA
Targeted Elimination of Cancer Stem Cells for AML Therapy$479,195
R01 · FY2013 · CA
Genomic Complexity and Clinical Outcome in Chronic Lymphocytic Leukemia$291,182
R01 · FY2013 · CA · contact PI
Genomic Complexity and Clinical Outcome in Chronic Lymphocytic Leukemia$308,524
R01 · FY2012 · CA · contact PI
Genomic Complexity and Clinical Outcome in Chronic Lymphocytic Leukemia$308,596
R01 · FY2011 · CA · contact PI
Genomic Complexity and Clinical Outcome in Chronic Lymphocytic Leukemia$318,211
R01 · FY2010 · CA · contact PI
Genomic Complexity and Clinical Outcome in Chronic Lymphocytic Leukemia$318,281
R01 · FY2009 · CA · contact PI
Genomic Profiling and clinical Outcome in Chronic Lymphocytic Leukemia$149,048
R21 · FY2008 · CA · contact PI
Genomic Profiling and clinical Outcome in Chronic Lymphocytic Leukemia$182,400
R21 · FY2007 · CA · contact PI